2 insiders bought €3.1M of shares over the last 90 days, the latest filed 02 Oct 2026.
Alpha Cognition Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). 10 insiders have disclosed 53 filings since 18 October 2025.
No insider sold shares on the market over the period. Instead, the filings list 44 purchases totalling €4.9M, made by 2 insiders. The totals do not cover 7 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €963k, bought by Opaleye Management Inc. and made public on 24 July 2026 (0.59% of market cap). The buyers include 1 major shareholder and 1 senior executive.
With 53 filings in twelve months, the company is more active than the median of 19 filings across the 5,808 companies we follow on the same exchange. The full history, which starts in 2024, counts 49 purchases against 1 sale.
In the case of 5 purchases, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last purchase on record was published on 2 October 2026, which is 16 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Alpha Cognition Inc. Strong Buy (bullish), based on 5 analysts. Average price target: US$18.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 59 declarations
Alpha Cognition Inc. is a company focused on developing treatments for cognitive disorders, including Alzheimer's disease. It is listed on the XNAS market.
Purchases our model currently ranks for the recommendations list.
All recommendations